Study guide

16.1 Consent, ABN, Test Ordering, and PPM Restrictions

AMT Certified Medical Laboratory Assistant CMLA

Track your progress as you read

Finished sections get a check mark.

1 Introduction

1.1 Current Exam Facts 1.2 Blueprint Weights and Study Strategy

2 Chapter 2: Safety Terminology and Infection Control

2.1 Safety, Infection, and OSHA Terminology 2.2 Chain of Infection and Precautions 2.3 Isolation, Aseptic Technique, and Disease Prevention

3 Chapter 3: OSHA, HazCom, and Public-Health Reporting

3.1 OSHA Bloodborne Pathogens and Needlestick Safety 3.2 Hazard Communication, SDS, and GHS 3.3 Mandated Safety Rules and Public-Health Reporting

4 Chapter 4: Quality Assessment and Quality Control

4.1 Quality Control and Assessment Terminology 4.2 QC vs QA, Internal vs External QC, and Proficiency Testing 4.3 Daily QC, Temperature Logs, and Corrective Action 4.4 Instrument Maintenance and Calibration in CMLA Scope

5 Chapter 5: Waived-Test Integrity and Confirmatory Testing

5.1 Off-Label Waived Testing and High-Complexity Default 5.2 Following Manufacturer Instructions for Waived Tests 5.3 Confirmatory and Supplemental Testing

6 Chapter 6: Phlebotomy Foundations

6.1 Phlebotomy Terminology and Equipment 6.2 Serum, Plasma, Whole Blood, and Anticoagulation 6.3 Patient Identification and Container Identification

7 Chapter 7: Venipuncture, Order of Draw, and Specimen Integrity

7.1 Patient Preparation and Physiologic Effects 7.2 Vein Selection and Venipuncture Technique 7.3 Order of Draw and Tube Additives 7.4 Short Draws, Hemolysis, and Plasma-on-Cells Limits

8 Chapter 8: Capillary Collection, Processing, and Legal Specimens

8.1 Capillary Puncture Including Infants 8.2 Post-Care, Labeling, Transport, Processing, and Send-Outs 8.3 Specimens Used as Legal Evidence

9 Chapter 9: Non-Blood Collection and Preanalytical Errors

9.1 Urine Collection Types and Patient Instruction 9.2 Urine Suitability, Storage, Preservatives, and Rejection 9.3 Other Specimens and Time/Temperature Requirements 9.4 Shipping, Slide Prep, Preanalytical Errors, and Complications

10 Chapter 10: Clinical Chemistry

10.1 Clinical Chemistry Terminology and Test Families 10.2 Chemistry Instrumentation, Cleaning, and Maintenance 10.3 Point-of-Care and Waived Chemistry Testing 10.4 Toxicology Within CMLA Scope

11 Chapter 11: Hematology and Coagulation

11.1 Hematology Terminology, Blood Functions, and Cell Types 11.2 Hematology Instrumentation, QC, and Calibration 11.3 Coagulation: PT, PTT, INR, Heparin, and Warfarin 11.4 Point-of-Care and Waived Hematology Tests

12 Chapter 12: Immunology, Serology, and Immunohematology

12.1 Antigen-Antibody Principles 12.2 Blood Types, Rh, and Immunohematology Basics 12.3 Waived Immunology, Serology, and Immunohematology Procedures

13 Chapter 13: Microbiology

13.1 Microbiology Terminology and Specimen Appropriateness 13.2 Aseptic Processing, Storage, and Transport of Micro Specimens 13.3 Media, Cultures, and Procedure Matching 13.4 Stains, KOH, Wet Preps, Reagents, and Controls

14 Chapter 14: Urinalysis and Microscopy

14.1 Urinalysis Terminology 14.2 Waived Urinalysis Procedures and Specimen Handling 14.3 Microscopy Parts, Magnification, Wet Prep, and Cleaning

15 Chapter 15: Basic Anatomy and Physiology

15.1 Anatomy Relevant to Laboratory Testing 15.2 Physiology Relevant to Laboratory Testing

16 Chapter 16: Legal, Ethical, and HIPAA Foundations

16.1 Consent, ABN, Test Ordering, and PPM Restrictions 16.2 Patient's Bill of Rights, Refusal, and Medicolegal Risk 16.3 Professional Appearance, Conduct, and Social Media 16.4 HIPAA Confidentiality and Record Release

17 Chapter 17: Clerical Skills, Communication, and Critical Values

17.1 Reports, Abnormal Results, and Critical-Value Notification 17.2 HIT Data, Inventory, Expirations, and Billing/Coding 17.3 Patient Instruction, Communication, Telephone, and Time Management

16.1 Consent, ABN, Test Ordering, and PPM Restrictions

Key Takeaways Explain This Topic AI

Routine venipuncture usually proceeds on implied consent after identity check and a brief explanation; written consent is reserved for named high-risk, research, or SOP-specified tests, not every blood draw.

An Advance Beneficiary Notice (ABN), Form CMS-R-131, is Medicare's waiver of financial liability issued before a test when Original Medicare is expected not to pay; it is not a consent form and not a diagnosis.

CLIA 42 CFR § 493.1241 requires a written or electronic test request from an authorized person under state law; a CMLA does not invent add-on tests because they seem useful.

Oral laboratory requests are allowed only if the laboratory solicits written or electronic authorization within 30 days and keeps that documentation (42 CFR § 493.1241(b)).

CLIA restricts provider-performed microscopy (PPM) to physicians, midlevel practitioners, and dentists; CMLA staff do not perform PPM wet mounts, KOH preps, or urine sediments as PPM even if they can operate a microscope.

Last updated: August 2026

CMLA Work Area IV (Patient Test Management, Communications, and Foundations) is 36 items, or 18.0% of the 200-question exam. Competency 11 opens with principles of liability in the laboratory . AMT IV.11.A.1–3 and IV.11.A.6 ask you to know consent forms , the Medicare Advance Beneficiary Notice (ABN) , regulations for ordering tests , and the rule that provider-performed microscopy (PPM) is restricted to providers only . These are four different legal tools. Mixing them is a classic miss: an ABN is not consent, a requisition is not a diagnosis, and a microscope on the bench is not a license for a CMLA to do PPM.

Quick Answer: Identify the patient, explain the stick, and proceed on implied consent if the patient extends an arm. Use a written consent only when SOP or law names that test. Issue Form CMS-R-131 (ABN) before a test when Original Medicare may not pay. Collect only what an authorized person ordered. Leave PPM to physicians, midlevel practitioners, and dentists.

Consent forms: informed, implied, written

Consent is a competent patient's agreement to a procedure after enough information to decide. Informed consent names the procedure, material risks, benefits, and alternatives, and includes the right to refuse. Express consent is spoken or written. Implied consent is shown by conduct. Written consent is a signed form stored in the record.

For routine venipuncture and most waived collections, implied consent is the everyday rule after you complete identification and a short explanation (what you are drawing, which arm, that they will feel a stick). Extending an arm, rolling up a sleeve, or seating at the chair after that explanation is agreement. You still stop for questions, flinching, or a spoken no. Implied consent is not a blank check to stick a sleeping, restrained, or arguing patient.

Written consent is for named high-risk or legally special work: surgery and other invasive procedures on the clinical side, research or experimental testing, and tests your standard operating procedure (SOP) or state law flags (some human immunodeficiency virus (HIV) , genetic, or forensic collections). Chapter 8.3 already covered chain of custody; here the point is that a legal blood-alcohol or workplace drug-screen kit often rides on a specific consent or collection form in addition to the kit paperwork. Do not treat a general admission consent as permission to ignore a test-specific form.

Capacity means the patient can understand and decide. Minors usually need a parent or legal guardian except where state law recognizes emancipation or a listed exception. If the patient lacks capacity, a personal representative (health-care agent, guardian) consents. Language barriers need a qualified interpreter per facility policy; do not default to a family member as the sole interpreter when SOP forbids it. If the patient cannot hear you, cannot see the form, or is in acute distress, you do not treat a shrug as informed consent.

A consent form is not a waiver of the standard of care. Signing does not authorize a wrong patient, a femoral stick outside CMLA routine, or a second attempt after a clear refusal.

ABN: Medicare's waiver of financial liability

AMT IV.11.A.2 names the waiver of liability for Medicare (Advance Beneficiary Notice - ABN) . The official form is CMS-R-131 , issued by providers including independent laboratories , physicians, practitioners, and suppliers to Original Medicare (fee-for-service) beneficiaries when Medicare payment is expected to be denied . CMS's Beneficiary Notices Initiative describes the ABN as the notice used to transfer potential financial liability in those cases. Guidelines live in the Medicare Claims Processing Manual (Publication 100-04), Chapter 30, beginning at Section 50.

An ABN is not informed consent, not HIPAA authorization, and not a diagnosis. It answers a money question: Medicare may not pay for this item, test, or service in this situation. Typical laboratory triggers include medical necessity (the diagnosis does not support coverage), frequency limits (screening or monitoring tests ordered more often than Medicare allows), and tests expected to be denied as experimental, investigational, or not proven effective . Screening laboratory tests often have set frequency windows; repeating inside that window is a classic ABN event. Physicians should forward completed ABNs to the laboratory; the lab still must have the notice before performing the noncovered service when a mandatory ABN applies.

Issue the ABN before the test, in a form the beneficiary can read, with the test named, the reason Medicare may not pay, and an estimated cost field. CMLA does not invent dollar amounts as exam facts; complete the estimate from the facility chargemaster or billing SOP, not from memory. The beneficiary (or representative) must choose one option, then sign and date:

Option What the beneficiary chooses What happens next

1 Wants the test and wants Medicare billed for an official payment decision You may collect payment now; if Medicare denies, the patient is liable; appeal rights attach to the Medicare decision

2 Wants the test but do not bill Medicare Patient accepts financial responsibility; no Medicare claim, so no Medicare appeal

3 Does not want the test Do not collect or bill for that listed test

Do not present an ABN after the draw and call it valid. Do not use an ABN as a blank to add tests the authorized person never ordered. Medicare Advantage and other payers use different notices; AMT names the Medicare ABN, not a homemade "we might not get paid" sticky note.

Regulations for ordering tests

42 CFR § 493.1241 (CLIA Standard: Test request) requires a written or electronic request from an authorized person . 42 CFR § 493.2 defines an authorized person as an individual authorized under State law to order tests or receive results, or both. That is a licensed provider acting inside state scope (physician, and in many states a nurse practitioner (NP) , physician assistant (PA) , dentist, or other listed practitioner)—not the assistant who likes extra chemistry.

You do not invent add-on tests. A complete blood count (CBC) order is not permission to add a basic metabolic panel because the patient looks dehydrated. A patient saying "while you are at it, check my thyroid" is a request to route to the authorized person, not a new order you write. Reflex testing that is built into a laboratory-approved protocol (for example a thyroid algorithm the medical director signed) is not freelance add-on work; it is part of the ordered test system. Direct-access testing, where it is legal, is still ordered through the laboratory's authorized pathway, not by the collector deciding the menu.

Oral requests: the laboratory may accept them if it solicits written or electronic authorization within 30 days and keeps the authorization or documentation of efforts to obtain it (§ 493.1241(b)). The requisition must solicit identity of the authorized person, patient identifiers, sex and age or date of birth, tests, specimen source when needed, collection date and time when appropriate, and any other information needed for accurate testing (§ 493.1241(c)). If you transcribe into the laboratory information system (LIS) , the entry must be accurate (§ 493.1241(e)). Wrong test code is a liability event, not a keyboard shrug.

PPM is providers only

AMT IV.11.A.6: regulations restrict provider-performed microscopy (PPM) to providers only . Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) , a Certificate for PPM procedures lets licensed physicians, midlevel practitioners (classically nurse midwife, NP, or PA ), and dentists perform a limited list of moderate complexity microscopic tests during the patient visit, plus waived tests. CDC's PPM materials (updated into 2026) still frame those three provider groups as the people who perform PPM and who may direct a PPM laboratory.

PPM tests are not waived. They use bright-field or phase-contrast microscopy and do not qualify as simple waived procedures. Common CMS/CDC PPM examinations include wet mounts (vaginal, cervical, or skin), potassium hydroxide (KOH) preparations, pinworm examinations, fern tests, post-coital mucus examinations, urine sediment examinations, nasal smears for granulocytes, fecal leukocyte examinations, and qualitative semen analysis limited to presence or absence of sperm and motility. A CMLA may prepare, transport, or accession specimens and may perform waived microscopy that the facility's certificate and competency actually allow (Chapter 14). That is not a PPM certificate and not permission to read a provider-only wet mount as if you were the clinician.

If the order is a PPM examination, the provider performs it. You do not "help" by looking down the ocular and calling yeast because the clinic is busy. Doing so is practicing outside CMLA and CLIA scope.

In practice

An Original Medicare patient arrives with a CBC and a screening fecal occult blood test ordered more often than Medicare frequency rules allow. You identify the patient, explain the venipuncture, and obtain implied consent for the CBC. Billing staff (or you, if trained) present a CMS-R-131 for the fecal test before collection; the patient selects Option 3, so you do not collect that stool kit. You do not add a comprehensive metabolic panel. You do not perform a vaginal wet mount under the PPM list.

Exam traps

Implied consent is not consent after a spoken refusal.

ABN is liability notice, not consent and not HIPAA.

Do not invent ABN dollar amounts as CMLA facts.

Authorized person is state-law authority, not whoever is standing nearest the rack.

PPM is physicians, midlevel practitioners, and dentists—not CMLA microscopy practice.

Loading diagram... Consent, ABN, Orders, and PPM